Clinical characteristics of chronic spontaneous urticaria in patients with Common variable immune deficiency and hypogammaglobulinemia

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access


Chronic spontaneous urticaria is a prevalent disease that is associated with various autoimmune, infectious (viral, bacterial, parasitic), and non-infectious inflammatory pathologies, and could occur in the symptom complex of other diseases, such as primary immunodeficiencies. Nowadays, data on the features of chronic spontaneous urticaria in patients with primary immunodeficiencies are accumulating. Common variable immune deficiency takes a special place in clinical practice among primary immunodeficiencies with impaired antibody synthesis and is associated with late-onset in adulthood, as well as the heterogeneity of its clinical manifestations, such as infectious and non-infectious complications, which can serve as a background for chronic urticaria development. Intravenous Immunoglobulin (IVIg) replacement therapy is the mainstay of treatment and prevention of infectious complications in these patients; however, immunomodulatory and anti-inflammatory effects can occur in high doses.

Herein, presented two clinical cases of patients with common variable immune deficiency and one with hypogammaglobulinemia who suffer from chronic spontaneous urticaria. The peculiarities of IVIg replacement therapy at urticaria were noted in these patients. The discussion presents the review of world literature and proposes key features for further investigations.

Full Text

Restricted Access

About the authors

Tatiana V. Latysheva

National Research Center ― Institute of Immunology Federal Medical-Biological Agency of Russia

ORCID iD: 0000-0003-1508-0640
SPIN-code: 8929-7644

MD, Dr. Sci. (Med.), Professor

Russian Federation, 24 Kashirskoe shosse, Moscow, 115522

Elena A. Latysheva

National Research Center ― Institute of Immunology Federal Medical-Biological Agency of Russia

ORCID iD: 0000-0002-1606-205X
SPIN-code: 2063-7973

MD, Dr. Sci. (Med.)

Russian Federation, 24 Kashirskoe shosse, Moscow, 115522

Inna V. Danilycheva

National Research Center ― Institute of Immunology Federal Medical-Biological Agency of Russia

ORCID iD: 0000-0002-8279-2173
SPIN-code: 4547-3948

MD, Cand. Sci. (Med.)

Russian Federation, 24, Kashirskoye shosse, Moscow, 115522

Evgeny A. Frolov

National Research Center ― Institute of Immunology Federal Medical-Biological Agency of Russia

Author for correspondence.
ORCID iD: 0000-0002-0800-5960
SPIN-code: 5963-4062


Russian Federation, 24 Kashirskoe shosse, Moscow, 115522


  1. Fricke J, Ávila G, Keller T, et al. Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta-analysis. Allergy. 2020;75(2):423–432. doi: 10.1111/all.14037
  2. Danilycheva IV, Ilyina NI, Luss LV, et al. Federal clinical guidelines for the diagnosis and treatment of urticaria. Russian Allergol J. 2016;(1):38–46. (In Russ).
  3. Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA²LEN/EDF/WAO guideline for the defi nition, classifi ca-tion, diagnosis and management of urticaria. Allergy. 2018;73(7):1393–1414. doi: 10.1111/all.13397
  4. Mikryukova NV, Kalinina NM. Immunopathogenesis of chronic urticaria in adults (scientific review). Preventive Clin Med. 2020;(3):77–85. (In Russ).
  5. Danilycheva IV. Autoimmune urticaria. Doctor. Ru. 2010;(2):41–44. (In Russ).
  6. Konstantinou GN, Asero R, Maurer M, et al. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy. 2009;64(9):1256–1268. doi: 10.1111/j.1398-9995.2009.02132.x
  7. Altrichter S, Peter HJ, Pisarevskaja D, et al. IgE mediated autoallergy against thyroid peroxidase ― a novel pathomechanism of chronic spontaneous urticaria? PloS One. 2011;6;(4):e14794. doi: 10.1371/journal.pone.0014794
  8. Bracken SJ, Abraham S, MacLeod AS. Autoimmune theories of chronic spontaneous urticaria. Front Immunol. 2019;10:627. doi: 10.3389/fimmu.2019.00627
  9. Abolhassani H, Amirkashani D, Parvaneh N, et al. Autoimmune phenotype in patients with common variable immunodefici.ency J Investig Allergol Clin Immunol. 2013;23(5):323–329.
  10. Cunningham-Rundles C. Autoimmune manifestations in common variable immunodeficiency. J Clin Immunol. 2008;28(1):42–45. doi: 10.1007/s10875-008-9182-7
  11. Azizi G, Tavakol M, Rafiemanesh H, et al. Autoimmunity in a cohort of 471 patients with primary antibody deficiencies. Expert Rev Clin Immunol. 2017;13(11):1099–1106. doi: 10.1080/1744666X.2017.1384312
  12. Xiao X, Miao Q, Chang C, et al. Common variable immunodeficiency and autoimmunity ― an inconvenient truth. Autoimmun Rev. 2014;13;(8):858–864. doi: 10.1016/j.autrev.2014.04.006
  13. Tangye, SG, Al-Herz, W, Bousfiha A, et al. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J Clin Immunol. 2020;40:66–81. doi: 10.1007/s10875-019-00737-x
  14. Kondratenko IV, Bologov AA. Primary immunodeficiency: textbook. Moscow: Media Index; 2020. 791 р. (In Russ).
  15. Hide M, Francis DM, Grattan C, et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med. 1993;328(22):1599–1604. doi: 10.1056/NEJM199306033282204
  16. Greaves M. Chronic urticaria. J Allergy Clin Immunol. 2000;105(4):664–672. doi: 10.1067/mai.2000.105706
  17. Kolkhir P, Borzova E, Grattan C, et al. Autoimmune comorbidity in chronic spontaneous urticaria: a systematic review. Autoimmun Rev. 2017;16;(12):1196–1208. doi: 10.1016/j.autrev.2017.10.003
  18. Latysheva EA. Primary immunodeficiency in adults: features of diagnosis and treatment [dissertation abstract]. Moscow; 2019. 48 р. (In Russ).
  19. Santos CV, Yacoub M. Chronic urticaria and common variable immunodeficiency (CVID): an association to remember BMJ Case Rep. 2021;14;(2):e239733. doi: 10.1136/bcr-2020-239733
  20. Comberiati P, Costagliola G, Carli N, et al. G Refractory chronic spontaneous urticaria treated with omalizumab in an adolescent with common variable immunodeficiency. Front Immunol. 2019;10:1700. doi: 10.3389/fimmu.2019.01700
  21. Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science. 2001;291;(5503):484–486. doi: 10.1126/science.291.5503.484
  22. Nimmerjahn F, Ravetch JV. The antiinflammatory activity of IgG: the intravenous IgG paradox. J Exp Med. 2007;204;(1):11–15. doi: 10.1084/jem.20061788
  23. Altschul A, Cunningham-Rundles C. Chronic urticaria and angioedema as the first presentations of common variable immunodeficiency J Allergy Clin Immunol. 2002;110;(4):664–665 doi: 10.1067/mai.2002.127002
  24. Smith AA, Humphrey J, McAuley JB, et al. Common variable immunodeficiency presenting as chronic urticaria. J Am Acad Dermatol. 2008;59(2 Suppl 1):S40–S41. doi: 10.1016/j.jaad.2007.09.011
  25. Frossi B, De Carli R, De Carli M. Chronic spontaneous urticaria in patients with common variable immunodeficiency. EMJ. 2018;3(4):95–102.
  26. Chechetkin AV, Bessmeltsev SS, Romanenko NA. The use of intravenous human immunoglobulin (immunovenin) in clinical practice. Methodological recommendations. Saint Petersburg; 2017. 7 р. (In Russ).
  27. Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science. 2001;291(5503):484–486. doi: 10.1126/science.291.5503.484
  28. Asero R. Are IVIG for chronic unremitting urticaria effective? Allergy. 2000;55(11):1099–1101. doi: 10.1034/j.1398-9995.2000.00829.x

Supplementary files

There are no supplementary files to display.

Copyright © Pharmarus Print Media, 2021

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies